home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

B-haemoglobin Gene Expression is Promising for B-Thalassaemia Gene Therapy

  July, 7 2000 2:51
your information resource in human molecular genetics

The heritable blood disorder b-thalassaemia is common in Mediterranean countries and in much of Asia - in the worst-affected places, such as Cyprus, as many as one in seven people carry the disease-causing mutation. At present, patients can be treated only with regular blood transfusions, iron-purging drugs or donor bone-marrow transplants. Because it is caused by the lack of a single protein molecule, this condition is high on the list of human diseases that might be tackled with gene therapy. Attempts to validate gene therapy approaches for tackling the disease in animal models have, however, been thwarted by insufficient expression of the necessary globin molecule.

This week [Nature, Vol. 406, Issue 6791, July 6, 2000], Michel Sadelain of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues report that they have solved this problem in a mouse b-thalassaemia model. They used recombinant lentiviruses to transfer the human b-haemoglobin gene, and its locus control region, into mouse blood (or haematopoietic) stem cells. The resulting bone marrow cells are stable and produce haemoglobin at potentially therapeutic levels when reconstituted into mice. This technique also provides a proof-of-principle for analogous stem-cell therapies.


Michel Sadelain tel +1 212 639 6190,
fax +1 917 432 2340,
e-mail m-sadelain@ski.mskcc.org

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.